Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Previous issues

Page Path
HOME > Browse articles > Previous issues
13 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 34(6); December 2002
Prev issue Next issue
Editorial
Therapeutics Approaches in the Treatment of Limited Small-Cell Lung Cancer
Joo Huyk Sohn, Joo Hang Kim
Cancer Res Treat. 2002;34(6):403-404.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.403
AbstractAbstract PDF
No abstract available.
  • 3,175 View
  • 16 Download
Close layer
Original Articles
Cancer Incidence in Korea
Hai Rim Shin, Yoon Ok Ahn, Jong Myon Bae, Myung Hee Shin, Duk Hee Lee, Choong Won Lee, Hee Choul Ohrr, Don Hee Ahn, Jacques Ferlay, Dornald Maxwell Parkin, Dae Kyu Oh, Jae Gahb Park
Cancer Res Treat. 2002;34(6):405-408.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.405
AbstractAbstract PDF
PURPOSE
We estimated the incidence of cancer in Korea.
MATERIALS AND METHODS
The indicence of cancer was estimated using national mortality data, and the incidence data from four frontier regional cancer registries, including Kangwha, Seoul, Busan and Deagu. These four registries served a population about seventeen million, which is almost 38% of entire population in Korea.
RESULTS
The overall age-standardized incidence rates (ASR) were 287.0 and 163.1 per 100,000 for males and females, respectively. Among males, stomach cancer was the most frequent (ASR 69.6), followed by lung cancers, including bronchus cancer (ASR 54.5), liver cancer (ASR 47.0) and colo-rectal cancer (ASR 25.2). The most frequent sites of cancer in females, by rank order, were stomach (ASR 26.8), breast (ASR 20.1), uterine cervix (ASR 18.0), colo-rectum (ASR 15.9), lung (ASR 13.0) and liver (ASR 12.0).
CONCLUSION
It is hoped that these results will provide valuable leads for cancer research and cancer control in Korea.

Citations

Citations to this article as recorded by  
  • Current Status of and Perspectives on Cervical Cancer Screening in Korea
    Sung-Chul Lim, Chong Woo Yoo
    Journal of Pathology and Translational Medicine.2019; 53(4): 210.     CrossRef
  • Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status
    W.S. Jung, C.H. Park, C.-K. Hong, S.H. Suh, S.J. Ahn
    American Journal of Neuroradiology.2018; 39(2): 273.     CrossRef
  • Patterns of Cancer in Kurdistan - Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq
    Najmaddin Khoshnaw, Hazha A Mohammed, Dana A Abdullah
    Asian Pacific Journal of Cancer Prevention.2016; 16(18): 8525.     CrossRef
  • A Prospective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection, Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head Cancer
    Jin-Young Jang, Mee Joo Kang, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Sang Jae Park, Sung-Sik Han, Dong Sup Yoon, Hee Chul Yu, Koo Jeong Kang, Sang Geol Kim, Sun-Whe Kim
    Annals of Surgery.2014; 259(4): 656.     CrossRef
  • Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?
    Sin Jae Kang, Mi Ran Jung, Oh Cheong, Young Kyu Park, Ho Goon Kim, Dong Yi Kim, Hoi Won Kim, Seong Yeob Ryu
    Journal of Gastric Cancer.2013; 13(4): 207.     CrossRef
  • Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection
    Seok Yun Kang, Jae Ho Han, Mi Sun Ahn, Hyun Woo Lee, Seong Hyun Jeong, Joon Seong Park, Yong Kwan Cho, Sang‐Uk Han, Young Bae Kim, Jang Hee Kim, Seung Soo Sheen, Ho‐Yeong Lim, Jin‐Hyuk Choi
    International Journal of Cancer.2012; 130(4): 948.     CrossRef
  • The prognostic significant of percentage drop in serum CEA post curative resection for colon cancer
    Won-Suk Lee, Jeong-Heum Baek, Keon Kuk Kim, Yeon Ho Park
    Surgical Oncology.2012; 21(1): 45.     CrossRef
  • Second-line chemotherapy for advanced gastric cancer in Korea
    Sun Kyung Baek, Si-Young Kim, Jae-heon Jeong, Kyung San Cho, Hwi-Joong Yoon
    Gastric Cancer.2012; 15(4): 345.     CrossRef
  • Correlation Between 18F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Advanced Lung Cancer
    Yun-Jung Choi, Byoung Chul Cho, Yong Hyu Jeong, Hyo Jung Seo, Hyun Jeong Kim, Arthur Cho, Jae Hoon Lee, Mijin Yun, Tae Joo Jeon, Jong Doo Lee, Won Jun Kang
    Nuclear Medicine and Molecular Imaging.2012; 46(3): 169.     CrossRef
  • Surgical outcome after incomplete endoscopic submucosal dissection of gastric cancer
    H Jung, J M Bae, M G Choi, J H Noh, T S Sohn, S Kim
    Journal of British Surgery.2011; 98(1): 73.     CrossRef
  • Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement
    In Hae Park, Sun Young Kim, Young-Woo Kim, Keun Won Ryu, Jun Ho Lee, Jong Seok Lee, Young-Iee Park, Noe Kyeong Kim, Sook Ryun Park
    Cancer Chemotherapy and Pharmacology.2011; 67(1): 127.     CrossRef
  • Inequalities in Medical Care Utilization by South Korean Cancer Patients According to Income: A Retrospective Cohort Study
    Tae Ho Yoon, Sang-Yi Lee, Chul-Woung Kim, Su Young Kim, Baek-Geun Jeong, Hyeung-Keun Park
    International Journal of Health Services.2011; 41(1): 51.     CrossRef
  • Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients
    Suk Hee Shin, Jae Moon Bae, Hun Jung, Min Gew Choi, Jun Haeng Lee, Jae Hyung Noh, Tae Sung Sohn, Sung Kim
    Journal of Surgical Oncology.2010; 101(5): 384.     CrossRef
  • Mucinous Gastric Cancer Presents with More Advanced Tumor Stage and Weaker β-Catenin Expression than Nonmucinous Cancer
    Min-Gew Choi, Chang Ohk Sung, Jae Hyung Noh, Kyoung-Mee Kim, Tae Sung Sohn, Sung Kim, Jae Moon Bae
    Annals of Surgical Oncology.2010; 17(11): 3053.     CrossRef
  • Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia
    Ho-Suap Hahn, Yi-Kyeong Chun, Yong-Il Kwon, Tae-Jin Kim, Ki-Heon Lee, Jae-Uk Shim, Jung-Eun Mok, Kyung-Taek Lim
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2010; 150(1): 80.     CrossRef
  • Multiple primary malignancies involving colorectal cancer—clinical characteristics and prognosis with reference to surveillance
    Won-Suk Lee, Jung Nam Lee, Sangtae Choi, Min Jung, Jeong-Heum Baek, Woon Kee Lee
    Langenbeck's Archives of Surgery.2010; 395(4): 359.     CrossRef
  • Clinical impact of tumor‐infiltrating lymphocytes for survival in stage II colon cancer
    Won‐Suk Lee, Sanghui Park, Woo Yong Lee, Seong Hyeon Yun, Ho‐Kyung Chun
    Cancer.2010; 116(22): 5188.     CrossRef
  • The Chemokine Receptor CCR4 is Expressed and Associated With a Poor Prognosis in Patients With Gastric Cancer
    Jun Ho Lee, Young-Suk Cho, Ji Young Lee, Myoung Cheorl Kook, Jong-Whan Park, Byung-Ho Nam, Jae-Moon Bae
    Annals of Surgery.2009; 249(6): 933.     CrossRef
  • Factors related to second cancer screening practice in disease-free cervical cancer survivors
    Sang Min Park, Chong Taik Park, Sang Yoon Park, Duk-Soo Bae, Joo Hyun Nam, Chi-Heum Cho, Jong Min Lee, Craig C. Earle, Young Ho Yun
    Cancer Causes & Control.2009; 20(9): 1697.     CrossRef
  • Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues
    Jin‐Sung Choi, Kyung‐Hee Kim, You‐Kyung Jeon, Sung‐Hee Kim, Sang‐Geun Jang, Ja‐Lok Ku, Jae‐Gahb Park
    International Journal of Cancer.2009; 124(6): 1258.     CrossRef
  • A Validation of Estimating the National Cancer Incidence in Korea using the Databases of 7 Population-based Regional Cancer Registries except Seoul

    Journal of Preventive Medicine and Public Health.2009; 42(2): 130.     CrossRef
  • An Estimation of the National Cancer Incidence in Korea for 2000-2002 Using the Databases of 8 Population-based Regional Cancer Registries

    Journal of Preventive Medicine and Public Health.2008; 41(6): 380.     CrossRef
  • Clinical Outcomes of Patients with Liver Cirrhosis Who Underwent Curative Surgery for Gastric Cancer: A Retrospective Multi-center Study
    Hyun Joo Jang, Jung Han Kim, Hun Ho Song, Kyung Hee Woo, Mi Kim, Sea Hyub Kae, Jin Lee, Ji Wong Cho, Jung Hun Kang, Soon Il Lee, Soo Jung Gong, Jung Ae Lee, Dae Young Zang
    Digestive Diseases and Sciences.2008; 53(2): 399.     CrossRef
  • Multiple Primary Cancers Including Colorectal Cancer
    Soo Hong Kim, Hyung Jin Kim, Jae Im Lee, Yoon Suk Lee, Won Kyung Kang, Jong Kyung Park, Seong Taek Oh
    Journal of the Korean Society of Coloproctology.2008; 24(6): 467.     CrossRef
  • The influence of reconstruction methods on food retention phenomenon in the remnant stomach after a subtotal gastrectomy
    Hyung Joong Jung, Jun Ho Lee, Keun Won Ryu, Jong Yeul Lee, Chan Gyoo Kim, Il Ju Choi, Young‐Woo Kim, Jae Moon Bae
    Journal of Surgical Oncology.2008; 98(1): 11.     CrossRef
  • Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Sook Ryun Park, Jong Seok Lee, Chan Gyoo Kim, Hark Kyun Kim, Myeong‐Cherl Kook, Young‐Woo Kim, Keun Won Ryu, Jun Ho Lee, Jae‐Moon Bae, Il Ju Choi
    Cancer.2008; 112(11): 2368.     CrossRef
  • A New Suggestion for the Radiation Target Volume After a Subtotal Gastrectomy in Patients With Stomach Cancer
    Heerim Nam, Do Hoon Lim, Sung Kim, Won Ki Kang, Tae Sung Sohn, Jae Hyung Noh, Yong Il Kim, Chan Hyung Park, Chul Keun Park, Yong Chan Ahn, Seung Jae Huh
    International Journal of Radiation Oncology*Biology*Physics.2008; 71(2): 448.     CrossRef
  • Identification of Differentially Expressed Genes in Microsatellite Stable HNPCC and Sporadic Colon Cancer
    Won-Suk Lee, Gilju Seo, Hee Jung Shin, Seong Hyeon Yun, Haeran Yun, Naeyun Choi, Jinseon Lee, Daesoon Son, Jisook Cho, Jhingook Kim, Yong Beom Cho, Ho-Kyung Chun, Woo Yong Lee
    Journal of Surgical Research.2008; 144(1): 29.     CrossRef
  • The Prevalence of Atrophic Gastritis and Intestinal Metaplasia according to Gender, Age and Helicobacter Pylori Infection in a Rural Population
    Hyun Ja Kim, Bo Youl Choi, Tae Joon Byun, Chang Soo Eun, Kyu Sang Song, Yong Sung Kim, Dong Soo Han
    Journal of Preventive Medicine and Public Health.2008; 41(6): 373.     CrossRef
  • Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors
    SUK‐JOON CHANG, HEE‐SUG RYU, KI‐HONG CHANG, SEUNG‐CHUL YOO, JONG‐HYUCK YOON
    Acta Obstetricia et Gynecologica Scandinavica.2008; 87(4): 476.     CrossRef
  • Feasibility of ovarian preservation in patients with early stage endometrial carcinoma
    Taek Sang Lee, Ji Ye Jung, Jae Weon Kim, Noh-Hyun Park, Yong-Sang Song, Soon-Beom Kang, Hyo-Pyo Lee
    Gynecologic Oncology.2007; 104(1): 52.     CrossRef
  • Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
    Keun-Wook Lee, Jee Hyun Kim, Tak Yun, Eun Kee Song, Im il Na, Hyunchoon Shin, So Yeon Oh, In Sil Choi, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Jong Seok Lee, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim
    Journal of Korean Medical Science.2007; 22(Suppl): S115.     CrossRef
  • Nitrate Intake Relative to Antioxidant Vitamin Intake Affects Gastric Cancer Risk: A Case-Control Study in Korea
    Hyun Ja Kim, Sang Sun Lee, Bo Youl Choi, Mi Kyung Kim
    Nutrition and Cancer.2007; 59(2): 185.     CrossRef
  • Abdominal Shape of Gastric Cancer Patients Influences Short-Term Surgical Outcomes
    Jun Ho Lee, Yong Hae Paik, Jong Seok Lee, Keun Won Ryu, Chan Gyoo Kim, Sook Ryeon Park, Young Woo Kim, Myeong Cherl Kook, Byung-ho Nam, Jae-Moon Bae
    Annals of Surgical Oncology.2007; 14(4): 1288.     CrossRef
  • Clinical Usefulness of Chest Radiography in Detection of Pulmonary Metastases After Curative Resection for Colorectal Cancer
    Won‐Suk Lee, Seong Hyeon Yun, Ho‐Kyung Chun, Woo Yong Lee, Haeran Yun
    World Journal of Surgery.2007; 31(7): 1502.     CrossRef
  • Educational Differences in Health Care Utilization in the Last Year of Life among South Korean Cancer Patients
    Soo-Young Choo, Sang-Yi Lee, Chul-woung Kim, Su Young Kim, Tae-Ho Yoon, Hai Rim Shin, Ok Ryun Moon
    Journal of Preventive Medicine and Public Health.2007; 40(1): 36.     CrossRef
  • Associations between Smoking, Screening, and Death Caused by Cervical Cancer in Korean Women
    Nemekhee Odongua, Young Moon Chae, Mee Ran Kim, Ji Eun Yun, Sun Ha Jee
    Yonsei Medical Journal.2007; 48(2): 192.     CrossRef
  • Autofluorescence Bronchoscopy
    Tae Won Jang
    Tuberculosis and Respiratory Diseases.2007; 62(4): 263.     CrossRef
  • A Phase-II Clinical Trial of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Gastric Cancer Patients
    Jun Ho Lee, Young-Woo Kim, Keun Won Ryu, Jong Ryul Lee, Chan Gyoo Kim, Il Ju Choi, Myoung Cheorl Kook, Byung-Ho Nam, Jae-Moon Bae
    Annals of Surgical Oncology.2007; 14(11): 3148.     CrossRef
  • Treatment outcomes in patients with signet ring cell carcinoma of the colorectum
    Won-Suk Lee, Ho-Kyung Chun, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Hae-Ran Yun, Sang-Hui Park, Sang Yong Song
    The American Journal of Surgery.2007; 194(3): 294.     CrossRef
  • Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
    Chang Moo Kang, Jun Young Kim, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Woo Jung Lee, Byong Ro Kim
    Yonsei Medical Journal.2007; 48(3): 488.     CrossRef
  • Decisions for extent of gastric surgery in gastric cancer patients: Younger patients require more attention than the elderly
    Jun Ho Lee, Keun Won Ryu, Jong Seok Lee, Jong Ryeol Lee, Chan Gyoo Kim, Il Ju Choi, Sook Ryun Park, Myeong‐Cherl Kook, Young‐Woo Kim, Jae‐Moon Bae
    Journal of Surgical Oncology.2007; 95(6): 485.     CrossRef
  • Prediagnosis Smoking, Obesity, Insulin Resistance, and Second Primary Cancer Risk in Male Cancer Survivors: National Health Insurance Corporation Study
    Sang Min Park, Min Kyung Lim, Kyu Won Jung, Soon Ae Shin, Keun-Young Yoo, Young Ho Yun, Bong Yul Huh
    Journal of Clinical Oncology.2007; 25(30): 4835.     CrossRef
  • Measuring the burden of major cancers due to smoking in Korea
    Heeyoung Lee, Seok‐Jun Yoon, Hyeong‐Sik Ahn
    Cancer Science.2006; 97(6): 530.     CrossRef
  • Learning Curve for Total Gastrectomy with D2 Lymph Node Dissection: Cumulative Sum Analysis for Qualified Surgery
    Jun Ho Lee, Keun Won Ryu, Jin-Hee Lee, Sook Ryun Park, Chan Gyoo Kim, Myoung Cheorl Kook, Byung-Ho Nam, Young-Woo Kim, Jae-Moon Bae
    Annals of Surgical Oncology.2006; 13(9): 1175.     CrossRef
  • Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells
    Joong-Won Park, Jung Eun Park, Jung Ahn Lee, Chang-Woo Lee, Chang-Min Kim
    Journal of Cancer Research and Clinical Oncology.2006; 132(3): 184.     CrossRef
  • Candidates for Curative Resection in Advanced Gastric Cancer Patients Who Had Equivocal Para-aortic Lymph Node Metastasis on Computed Tomographic Scan
    Jun Ho Lee, Yong Hae Paik, Jong Seok Lee, Ho Joon Song, Keun Won Ryu, Chan Gyoo Kim, Sook Ryeon Park, Myoung Cheorl Kook, Young Woo Kim, Jae-Moon Bae
    Annals of Surgical Oncology.2006; 13(9): 1163.     CrossRef
  • Rising prostate cancer rates in South Korea
    Sue Kyung Park, Lori C. Sakoda, Daehee Kang, Anand P. Chokkalingam, Eunsik Lee, Hai-Rim Shin, Yoon-Ok Ahn, Myung-Hee Shin, Choong-Won Lee, Duk-Hee Lee, Aaron Blair, Susan S. Devesa, Ann W. Hsing
    The Prostate.2006; 66(12): 1285.     CrossRef
  • Detection of Pre-invasive Endobronchial Tumors with D-light/Autofluorescence System
    Tae Won Jang, Chul Ho Oak, Bong Kwon Chun, Mann Hong Jung
    Journal of Korean Medical Science.2006; 21(2): 242.     CrossRef
  • Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database
    Hai-Rim Shin, Young-Joo Won, Kyu-Won Jung, Hyun-Joo Kong, Seon-Hee Yim, Jung-Kyu Lee, Hong-In Noh, Jong-Koo Lee, Paola Pisani, Jae-Gahb Park
    Cancer Research and Treatment.2005; 37(6): 325.     CrossRef
  • Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia
    Dae Kyung Sohn, Seung-Yong Jeong, Hyo Seong Choi, Seok-Byung Lim, Jin Myeong Huh, Dae-Hyun Kim, Dae Yong Kim, Young Hoon Kim, Hee Jin Chang, Kyung Hae Jung, Joong-Bae Ahn, Hyun Kyung Kim, Jae-Gahb Park
    Cancer Research and Treatment.2005; 37(1): 20.     CrossRef
  • Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer
    Keun-Wook Lee, Seock-Ah Im, Tak Yun, Eun Kee Song, Im il Na, Hyunchoon Shin, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Dong-Wan Kim, Tae-You Kim, Jong Seok Lee, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim
    Japanese Journal of Clinical Oncology.2005; 35(12): 720.     CrossRef
  • Gastric cancer surgery in cirrhotic patients: Result of gastrectomy with D2 lymph node dissection
    Jun Ho Lee
    World Journal of Gastroenterology.2005; 11(30): 4623.     CrossRef
  • Phase II Study of Irinotecan, 5-Fluorouracil and Leucovorin as First-line Therapy for Advanced Colorectal Cancer
    Sang Hoon Ji, Young Suk Park, Jeeyun Lee, Do Hyoung Lim, Byeong-Bae Park, Keun Woo Park, Jung Hun Kang, Se-Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young-Hyuck Im, Won Ki Kang, Keunchil Park
    Japanese Journal of Clinical Oncology.2005; 35(4): 214.     CrossRef
  • 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals
    Hai-Rim Shin, Kyu-Won Jung, Young-Joo Won, Jae-Gahb Park
    Cancer Research and Treatment.2004; 36(2): 103.     CrossRef
  • Three Cases of Synchronous Solid Tumor and Multiple Myeloma
    Sang Hoon Ji, Joon Oh Park, Jeeyun Lee, Mi Jung Oh, Do Hyoung Lim, Byeong-Bae Park, Keun Woo Park, Se-Hoon Lee, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H Lee, Keunchil Park
    Cancer Research and Treatment.2004; 36(5): 338.     CrossRef
  • Effects of obesity on breast cancer stage at diagnosis in Korean women
    Y A Kim, C W Lee
    European Journal of Cancer Prevention.2004; 13(1): 13.     CrossRef
  • 2001 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 134 Hospitals
    Hai-Rim Shin, Young-Joo Won, Kyu-Won Jung, Jae-Gahb Park
    Cancer Research and Treatment.2004; 36(1): 19.     CrossRef
  • Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer
    Hyuk-Chan Kwon, Kyoung Tae Kim, Shin Ae Lee, Jong-Sung Park, Sung-Hyun Kim, Jae-Seok Kim, Hyo Jin Kim
    Cancer Research and Treatment.2004; 36(2): 115.     CrossRef
  • Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view
    D H Lim, D Y Kim, M K Kang, Y I Kim, W K Kang, C K Park, S Kim, J H Noh, J W Joh, S H Choi, T S Sohn, J S Heo, C H Park, J O Park, J E Lee, Y J Park, H R Nam, W Park, Y C Ahn, S J Huh
    British Journal of Cancer.2004; 91(1): 11.     CrossRef
  • Epidemiology and Risk Factors of Breast Cancer
    Keun-Young Yoo
    Journal of the Korean Medical Association.2003; 46(6): 482.     CrossRef
  • Epidemiology of Diseases of the Colo-rectum and Anus
    Bong Hwa Lee
    Journal of the Korean Medical Association.2003; 46(7): 565.     CrossRef
  • 4,911 View
  • 31 Download
  • 62 Crossref
Close layer
Concurrent Etoposide/Cisplatin Combination Chemotherapy (EP) and Thoracic Radiotherapy after Two Cycles of EP for Limited Stage Small Cell Lung Cancer
Hee Jung Sohn, Sang We Kim, Jin Hee Ahn, Hye Jin Kang, Sarah Park, Heon Nyoung Jung, Cheol Won Suh, Woo Kun Kim, Sang Wook Lee, Eun Kyung Choi, Sang Do Lee, Woo Sung Kim, Dong Sun Kim, Won Dong Kim, Jung Shin Lee
Cancer Res Treat. 2002;34(6):409-415.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.409
AbstractAbstract PDF
Purpose
s: Although the standard management of limited stage small cell lung cancer is concurrent platinum-based chemotherapy with thoracic radiotherapy (TRT), the optimal timing of the TRT remains controversial. We investigated the feasibility of concurrent chemoradiation for the patients with limited stage small cell lung cancer after 2 cycles of combination chemotherapy with Etoposide/Cisplatin (EP).
MATERIALS AND METHODS
EP consisted of Etoposide 100 mg/m2 on day 1 to 3 and Cisplatin 70 mg/m2 on day 1. Six cycles were given to the responders every 4 weeks. Total 55 Gy (1.8 Gy once-daily or 1.2 Gy twice-daily, 5 days per week) of TRT were given to the patients who showed at least a partial response after 2 cycles of EP. The other patients were treated by the physician's decision. The patients with complete remission were recommended to receive prophylactic cranial irradiation.
RESULTS
Fifty patients were enrolled. Thirty-five (70%) of them showed responses (2 complete remissions and 33 partial remissions) after 2 cycles of EP. Thirty-three of the responders were given TRT starting with the 3rd cycle of EP. The nonresponders were treated with salvage chemotherapy and TRT. After completion of treatment for 50 patients, the overall response rate was 86% (29 complete remissions, 14 partial remissions). One patient (2%) showed stable disease, and 6 (12%) showed a progressive disease. The median progression free survival was 326 days and the median survival time was 410 days. One-, 2-, 3-, 4- and 5-year survival rates were 62%, 24%, 14%, 9% and 6%, respectively. As hematologic toxicities during chemoradiation, 35.1% with grade III/IV neutropenia and 18.9% with grade III/IV thrombocytopenia were noted. Grade II/III radiation pneumonitis and radiation esophagitis were noted in 5/1 and 13/1 patients (15.2%/ 3.0% and 39.4%/3.0%), respectively. One patient died of septicemia during chemoradiation.
CONCLUSION
The concurrent EP and TRT after 2 cycles of EP was feasible in limited stage small cell lung cancer. Further study is required for the indentification of optimum timing of TRT during combination chemotherapy.

Citations

Citations to this article as recorded by  
  • Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer
    In-Bong Ha, Bae-Kwon Jeong, Hojin Jeong, Hoon-Sik Choi, Gyu-Young Chai, Myoung-Hee Kang, Hoon Gu Kim, Gyeong-Won Lee, Jae-Beom Na, Ki-Mun Kang
    Radiation Oncology Journal.2013; 31(4): 185.     CrossRef
  • 5,540 View
  • 32 Download
  • 1 Crossref
Close layer
A Phase II Study of Ifosfamide, Carboplatin, and Epirubicin (ICE) Combination Chemotherapy for Extensive Disease of Small Cell Lung Cancer
Jae Ho Byun, In Sook Woo, Hun Ho Song, Keun Seok Lee, Jin Seok Ahn, Dae Young Jang, Jung Ae Lee, Young Lee Park, Young Suk Park
Cancer Res Treat. 2002;34(6):416-420.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.416
AbstractAbstract PDF
PURPOSE
To evaluate the efficacy and safety of ifosfamide, carboplatin and epirubicin (ICE) combination chemotherapy for extensive disease small cell lung cancer (SCLC) patients, who had received no previous chemotherapy, we performed phase II trial between August 1998 and January 2001.
MATERIALS AND METHODS
The study group comprised of 21 patients. Ifosfamide, 1,500 mg/m2, was given with mesna, 900 mg/m2, intravenously for 12 hours on days 1, 2 and 3, and carboplatin, 4.5 mg/ml/min, for target AUC, and epirubicin, 60 mg/m2, were given intravenously for 90 minutes on day 1. The cycle of treatment was repeated at 4 week intervals.
RESULTS
Twenty-one patients with extensive disease SCLC were treated at Hallym University between August 1998 and January 2001. One patient was unable to be evaluated because of lost to follow-up. Of the 20 patients able to be evaluated, an objective response was observed in 13 (65%). There were no complete responses. The median response duration, time to progression and median overall survival were 15.4, 18.3 and 34 weeks, respectively. Toxicities were acceptable, with dose reduction for myelosuppression necessary in only a minority of the patients. A total of 85 cycles of chemotherapy were given to the patients. The median number of cycles completed was 4. Grade III and IV hematological toxicities included anemia (4.7%), neutropenia (3.5%) and thrombocytopenia (3.5%). Most non-hematological toxicities were grade I or II.
CONCLUSION
These results suggested that ICE combination chemotherapy for extensive disease SCLC is effective, and can be safely administered with acceptable toxicities.
  • 4,190 View
  • 24 Download
Close layer
Oral Etoposide, Ifosfamide and Cisplatin in the Treatment of Extensive Disease Small Cell Lung Cancer
Seok Jin Kim, Hwa Jung Sung, Kyong Hwa Park, So Young Yoon, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Kwang Taek Kim, Young Ho Choi, Jun Suk Kim
Cancer Res Treat. 2002;34(6):421-425.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.421
AbstractAbstract PDF
PURPOSE
The combination of cisplatin and etoposide has been a common first line regimen for the treatment of small cell lung cancer (SCLC). The schedule dependence, and equal efficacy, of the oral and intravenous dosing of etoposide has led to prolonged administration of oral etoposide, which is known to produce an encouraging response in SCLC. To improve the efficacy of the cisplatin/etoposide combination, we administered oral etoposide, with added ifosfamide, which had significant single agent activity against SCLC. We conducted this study to evaluate the efficacy and toxicity of the cisplatin, ifosfamide and oral etoposide (PIE) combination in patients with extensive small cell lung cancer.
MATERIALS AND METHODS
Twenty-five patients with histologically confirmed extensive small cell lung cancer were enrolled into this study between January 2000 and May 2002. They were treated with, cisplatin at 20 mg/ m2/day, ifosfamide 1.5 g/m2/day, with mesna (all given intravenously on Days 1~3), and oral etoposide 50 mg/m2 on days 4~17. This cycle was repeated every 4 weeks for up to 6 cycles. We evaluated the corresponding disease responses and toxicities.
RESULTS
The patients' characteristics were as follows: median age 65 years (32~75), 19 males and 6 females. The performance stati were ECOG 0 in 3 patients, ECOG 1 in 12 and ECOG 2 in 10. Sixteen patients had a partial response, 2 had a stable disease and 4 had a progressive disease. Thus, the overall objective response rate was 72.7% (95% CI: 49.6~88.4%), with a median response duration of 7 months (95% CI: 3.5~10.5 months). Myelosuppression was the major observed toxicity. Grades III and IV neutropenia were observed in 42 (46.1%) of the 91 cycles. Significant non-hematological toxicities (>or=Grade III) were uncommon, with the exception of nausea and vomiting.
CONCLUSION
The response rate to the combination of cisplatin, ifosfamide and oral etoposide was similar to that of other combination chemotherapy studies in patients with extensive disease small cell lung cancer. The toxicity of the regimen was considered acceptable.
  • 4,504 View
  • 26 Download
Close layer
SB203580, a P38 MAPK Inhibitor, Blocks in vitro Invasion by Human Gastric SNU-638 Cells
Ju Chae Park, Hyeon Gyeung Yoo, Hong Su Kim, Min A Jung, Mi Ha Kim, Sang Won Han, Kee Oh Chay, Boo Ahn Shin, Bong Whan Ahn, Young Do Jung
Cancer Res Treat. 2002;34(6):426-431.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.426
AbstractAbstract PDF
PURPOSE
The role of P38 mitogen-activated protein kinase (MAPK) in gastric cancer invasion has not yet been determined. In this study, we examined the effects of SB203580, a specific P38 MAPK inhibitor, on the in vitro invasion of gastric cancer and upon the molecules involved in this process.
MATERIALS AND METHODS
Human gastric cancer SNU-638 cells were maintained in RPMI 1640 supplemented with 10% FBS. BIOCOAT matrigel invasion chambers were used to examine in vitro invasiveness, zymography for gelatinase activity, CAT assay for uPA promoter activity and Western and Northern blotting to determine protein and mRNA levels, respectively.
RESULTS
Treatment of SNU-638 cells with SB203580, a specific P38 MAPK inhibitor, reduced in vitro invasiveness, dose-dependently. SB203580 treatment was found to decrease both mRNA expression and uPA promoter activity in gastric SNU-638 cells. In vitro invasion of SNU-638 cells was partially abrogated by uPA-neutralizing antibodies. The activities of MMPs were not significantly altered by SB203580.
CONCLUSION
Our results suggest that P38 MAPK is a potential therapeutic target for inhibiting uPA-dependent gastric tumor invasiveness and metastasis.
  • 3,584 View
  • 25 Download
Close layer
No Association between Catalase Gene Polymorphism and Gastric Carcinoma and Hepatocellular Carcinoma in Koreans
Ji Hyun Lee, Ran Young Park, Chang Soo Lee, Euh Jun Jeoung, Su Youn Nam, Jae Gun Lee, Kye Young Han, Hee Jae Lee, Joo Ho Chung, Yun Gul Ahn, Sung Vin Yim, Jae Young Cho, Yeon Hee Park
Cancer Res Treat. 2002;34(6):432-435.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.432
AbstractAbstract PDF
PURPOSE
Oxidative stress has been implicated in the pathogenesis of various diseases. Catalase is one of the main defense mechanisms against oxidative stress. To examine the possible relationship between oxidative stress, and gastric and hepatocellular carcinomas, HinfI restriction length polymorphism (RFLP) in the human catalase gene was assessed.
MATERIALS AND METHODS
The genotype and allele frequencies in the promoter region of the catalase gene were studied by PCR-RFLP in 108 Korean controls, 80 Korean gastric carcinoma (GC) and 106 Korean hepatocellular carcinoma (HCC) patients.
RESULTS
No statistically significant differences were found in the genotypic distribution and allelic frequencies between the controls and both types of carcinoma patient.
CONCLUSION
To address the possible contribution of oxidative stresses to the pathogenesis of gastric and hepatocellular carcinomas, the associations between the catalase gene polymorphism and GC and HCC susceptibilities were studied. As a result, the catalase gene polymorphism was found not to be determinant of GC and HCC susceptibilities. Further studies are required on various other oxidative stress related genes to elucidate the mechanisms of GC and HCC.

Citations

Citations to this article as recorded by  
  • Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
    Saloni Sinha, Nora Hassan, Robert E. Schwartz
    Hepatology.2024; 79(2): 482.     CrossRef
  • Two common functional catalase gene polymorphisms (rs1001179 and rs794316) and cancer susceptibility: evidence from 14,942 cancer cases and 43,285 controls
    Kang Liu, Xinghan Liu, Meng Wang, Xijing Wang, Huafeng Kang, Shuai Lin, Pengtao Yang, Cong Dai, Peng Xu, Shanli Li, Zhijun Dai
    Oncotarget.2016; 7(39): 62954.     CrossRef
  • Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population
    Yanqiong Liu, Li Xie, Jiangyang Zhao, Xiuli Huang, Liuying Song, Jingrong Luo, Liping Ma, Shan Li, Xue Qin
    Medicine.2015; 94(13): e702.     CrossRef
  • 4,849 View
  • 21 Download
  • 3 Crossref
Close layer
l-myc Polymorphism in Gastric Cancer, Lung Cancer, and Hepatocellular Carcinoma
Min Su Park, Sae Bin Jung, Yeon Hee Park, Bong Seog Kim, Hyun Ju Park, Hee Jae Lee, Soon Ae Kim, Bong Keun Choe, Joo Ho Chung
Cancer Res Treat. 2002;34(6):436-438.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.436
AbstractAbstract PDF
PURPOSE
This study was performed to see if a particular polymorphism in the l-myc, a nuclear oncogene at the 1p32 locus, might be associated with greater risk of gastric cancer, lung cancer and hepatocellular carcinomas (HCC) in Korean patients.
MATERIALS AND METHODS
Genomic DNA, derived from patients diagnosed with gastric cancer (n=57), lung cancer (n=39), HCC (n=35) and healthy individuals (n= 176), was examined. The l-myc polymorphism under study was visualized by PCR followed by EcoRI digestion.
RESULTS
There was no significant difference in the distribution of the l-myc polymorphism genotypes and allele frequencies between the cancer patients and the controls.
CONCLUSION
The l-myc polymorphism does not appear to be indicative of elevated risk of cancers of the stomach, lung and HCC.

Citations

Citations to this article as recorded by  
  • An E2F5-TFDP1-BRG1 Complex Mediates Transcriptional Activation of MYCN in Hepatocytes
    Zhiwen Fan, Ming Kong, Xiulian Miao, Yan Guo, Haozhen Ren, Jinglin Wang, Shuai Wang, Ning Tang, Longcheng Shang, Zhengyi Zhu, Hanyi Liu, Wei Zhu, Xiaolei Shi
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • 3,995 View
  • 25 Download
  • 1 Crossref
Close layer
High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Persistent/Relapsed Ovarian Cancer
So Eun Kim, Jong Ho Won, Hyun Soo Kim, Joon Sung Park, Chan Kyu Kim, Kyu Taeg Lee, Sung Kyu Park, Seung Ho Baick, Dae Sik Hong, Hee Sook Park, Hugh Chul Kim
Cancer Res Treat. 2002;34(6):439-443.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.439
AbstractAbstract PDF
PURPOSE
High dose chemotherapy (HDC) is increasingly being used for ovarian cancer. Although early studies of autotransplantation for advanced ovarian cancer have been encouraging, most reported series were small, and no randomized trials have been reported. HDC and autologous hematopoietic stem cell transplantation were rarely performed in patients with ovarian cancer in Korea, and no results have been reported with the exception of one case report.
MATERIALS AND METHODS
We retrospectively analyzed 10 patients with refractory or relapsed ovarian cancer having received HDC and autologous peripheral blood stem cell transplantation (APBSCT), between January 1996 and September 1998, at the Soon Chun Hyang and Ajou University Hospitals.
RESULTS
Ten patients were treated with HDC and APBSCT. Six patients achieved complete response (CR) and 1 a partial response (PR), with a response rate of 70%. Three patients did not respond following mobilization chemotherapy, and failed to respond after HDC. The median duration of progression free survival (PFS) and overall survival (OS) were 6 (4~46) and 13 (3~50+) months, respectively. The median duration of OS of the responders following mobilization chemotherapy was 23 (8~50+) compared with 12 (3~18) months of the non- responders. With regard to the treatment related toxicity, 8 patients had neutropenic fevers, and bacteremia was documented in 4. The non-hematological toxicities were never life threatening, and there were no treatment related deaths.
CONCLUSION
HDC, followed by APBSCT, is well-tolerated patients with refractory or relapsed ovarian cancer, and following mobilization chemotherapy the responders survived longer than the non-responders.

Citations

Citations to this article as recorded by  
  • Analysis of chromosomal changes in serous ovarian carcinoma using high‐resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease
    Sang Wun Kim, Jae Wook Kim, Young Tae Kim, Jae Hoon Kim, Sunghoon Kim, Bo Sung Yoon, Eun Ji Nam, Hye Yeon Kim
    Genes, Chromosomes and Cancer.2007; 46(1): 1.     CrossRef
  • 4,482 View
  • 17 Download
  • 1 Crossref
Close layer
Antisense Deoxyoligonucleotides Inhibit Activities of Matrix Metalloproteinase-2 in Human Fibrosarcoma HT1080 Cells
Jung Sun Park, Dong On Yang, Seon Hee Lim, Hyeon Gyeong Yoo, Heyon Na Cho, Young Do Jung, Sae Jong Kim, Sun Sik Chung, Boo Ahn Shin
Cancer Res Treat. 2002;34(6):444-449.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.444
AbstractAbstract PDF
PURPOSE
MMP-2, 72 kDa-type IV collagenase, plays a major role in the migration and growth of tumor cells, a process that requires the disintegration of basement membrane. Activation of MMP-2 is correlated with the invasiveness of various tumors. The aim of this study was to determine the sequence-specific phosphorothioated oligodeoxynucleotides (ODNs) inhibiting the translation of MMP-2 mRNA and the subsequent invasiveness of tumor cells.
MATERIALS AND METHODS
Eight types of antisense ODNs were designed and each (8micro gram/ml) were transfected into HT1080 cells. The effects of these antisense ODNs on MMP expression were examined by gelatin zymography, Western blot, Northern blot and matrigel assay.
RESULTS
Antisense-5 (+904~923), antisense-6 (+1274~+1293) and antisense-7 (+1646~+1665) reduced the MMP-2 activity of the culture supernatant in HT1080 fibrosarcoma cells. Treatment with antisense-6 showed inhibition of MMP-2 mRNA and protein, and in vitro invasion in a dose-dependent manner.
CONCLUSION
Antisense-6 might be one of the therapeutic candidates for tumor invasion and metastasis.
  • 3,490 View
  • 18 Download
Close layer
Ependymoma: a Retrospective Analysis of 25 Cases
Young Seok Kim, Seung Do Ahn, Eun Kyung Choi, Jong Hoon Kim, Sang Wook Lee, Young Ju Noh, Chang Jin Kim, Jeong Hoon Kim, Byung Duk Kwun
Cancer Res Treat. 2002;34(6):450-456.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.450
AbstractAbstract PDF
PURPOSE
We evaluated the patterns of failure, survival rate, prognostic factors and treatment related complication in postoperative radiation treatment of patients with ependymoma.
MATERIALS AND METHODS
We retrospectively analyzed 25 patients with histologically confirmed ependymoma treated between Jun. 1990 and Jun. 2001 with postoperative radiotherapy at Asan Medical Center. The study group comprised of 16 men and 9 women, with a median age of 23 years; including 6 supratentorial, 15 infratentorial and 4 spinal cord lesions. The extents of resection were ranked as either: gross total, near total, subtotal, partial resection or biopsy, with these types of surgical resection being performed in 13, 3, 6, 1 and 2 patients, respectively. Twelve of the patients had low grade ependymoma, and the other 13 a high grade tumor. The postoperative irradiation was administered using 4 MV or 6 MV photons, up to median dose of 55.0 Gy (range, 45.0~59.4 Gy), with the radiation field encompassing the preoperative tumor volume plus a 2 cm margin. Only 8 of the patients received either pre- or postoperative chemotherapy. The median follow-up period of survivors was 43 months.
RESULTS
Ten of the 25 patients (40%) developed a recurrence, and 5 died. Of the 10 recurred patients, 6 showed an in-field recurrence, and one developed both an in-field and an out of field recurrence. The remaining 3 patients showed an out of field recurrence, including one case with a leptomeningeal recurrence. The 5-year overall survival, and progression-free, survival rates were 74.0 and 56.1%, respectively. The histological grades were statistically significant prognostic factors of the overall and progression-free survival rates. There were no significant treatment related complications, with the exception of one case of panhypopituitarism, which occurred 30 months after completion of the radiotherapy.
CONCLUSION
The main pattern of recurrence was due to local failure. In order to improve the local control, and to reduce complications, advanced radiation treatment techniques, such as 3 dimensional radiotherapy, may be needed.

Citations

Citations to this article as recorded by  
  • Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study
    Hwa Kyung Byun, Seong Yi, Hong In Yoon, Se Hoon Kim, Jaeho Cho, Chang-Ok Suh
    Journal of Neuro-Oncology.2018; 140(3): 649.     CrossRef
  • 4,362 View
  • 22 Download
  • 1 Crossref
Close layer
Case Reports
A Case of Primary Gastric Choriocarcinoma Presenting with Amenorrhea
Seung Hyun Nam, Seock Ah Im, Ki Sun Bae, In Sook Kang, Jung Mi Kwon, Kyung Eun Lee, Hye Sung Moon, Sun Hee Sung, Woon Sup Han, Chu Myong Seong, Soon Nam Lee
Cancer Res Treat. 2002;34(6):457-460.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.457
AbstractAbstract PDF
Primary gastric choriocarcinomas are very rare, and their prognosis is extremely poor. A 37-year-old woman presented with amenorrhea, vaginal spotting and severe nausea, which mimicked a pregnancy and gestational trophoblastic disease. The serum level of the beta-subunit of human chorionic gonadotrophin (beta-hCG) was significantly increased. An endoscopic biopsy of the stomach mass showed the features of a choriocarcinoma, with marked anaplasia and necrosis. Immunohistochemical staining for beta-hCG showed positive results in the choriocarcinoma. Chemotherapy for the choriocarcinoma was administered, but she died 8 months following diagnosis.

Citations

Citations to this article as recorded by  
  • Primary Gastric Choriocarcinoma: Two Case Reports and Review of the Literatures
    Jung Ho Yoon, Min Soo Kim, Eun Hee Kook, Se Han Ahn, Se Young Jeong, Min Sung Han, Jung Kwon Huh, Hye Jin Kang, Im Il Na, Soo Youn Cho, Sang Bum Kim, Baek Yeol Ryoo, Sung Hyun Yang
    Cancer Research and Treatment.2008; 40(3): 145.     CrossRef
  • 4,172 View
  • 34 Download
  • 1 Crossref
Close layer
A Case of Extraskeletal Ewing's Sarcoma Arising from Duodenum
Sang Il Kim, Yeon Hee Park, Seong Jun Choi, Baek Yeol Ryoo, Seung Sook Lee, Hyun Bae Son, Yo Ahn Suh, Dae Han Kim, Sung Ho Kim, Kui Sung Choi, Yoong Ju Kweon
Cancer Res Treat. 2002;34(6):461-465.   Published online December 31, 2002
DOI: https://doi.org/10.4143/crt.2002.34.6.461
AbstractAbstract PDF
Extraskeletal Ewing's sarcomas (EES) are rare. Recently, Ewing's sarcoma of the bone, primitive neuroectodermal tumor (PNET), Askin tumor and EES have been included into the family of Ewing's tumors, due to the overlapping features relating to their clinico-pathological and cytogenetic appearance. We experienced a case of an EES arising from the duodenum in a 14-year-old girl who presented with hematemesis and epigastric discomfort. A duodenal biopsy specimen revealed the infiltration of small round cells and rich vasculatures, with immunohistochemical finding of MIC-2 (CD99) (+), vimentin (+), CD56 (NCAM) (+), LCA (-), T-cell (-), B-cell (-), CD43 (-) and CD68 (-). She was treated with several cycles of multiagent chemotherapy, and achieved an initial partial response, but rapid progression of tumor followed, so she was treated with surgical excision. This is the first case report of an EES arising from the duodenum in the literature.

Citations

Citations to this article as recorded by  
  • Ewing’s sarcoma of the duodenum: a rare clinical condition managed with surgical resection
    Saniya Saiyed, Omar A Mownah, Matthew J Bowles, Aditya Kanwar
    BMJ Case Reports.2023; 16(6): e249686.     CrossRef
  • 4,485 View
  • 41 Download
  • 1 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP